Cover Image

The Landscape of Clinical Implementation of Pharmacogenetic Testing in Central China: A Single-Center Study

Jingmin Zhang,1,2 Guangzhao Qi,1,2 Chao Han,1,2 Yubing Zhou,1,2 Yongjie Yang,1 Xinru Wang,1,2 Suna Liu,3 Xiaojian Zhang1,2 1Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, People's Republic of China; 2Henan Key Laboratory for Precision Clinical Pharmacy...

Full description

Saved in:

Bibliographic Details
Main Authors:	Zhang J (Author), Qi G (Author), Han C (Author), Zhou Y (Author), Yang Y (Author), Wang X (Author), Liu S (Author), Zhang X (Author)
Format:	Book
Published:	Dove Medical Press, 2021-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Therapeutic Drug Monitoring and Pharmacogenetic Testing in Northern China
by: Chunyan Zhang, et al.
Published: (2021)

Robotic single-site surgery for mature cyst teratoma cystectomy: an initial case series study in a single medical center in China
by: Liu Z, et al.
Published: (2019)

Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
Published: (2020)

Pharmacogenetic landscape of pain management variants among Mediterranean populations
by: Haifa Jmel, et al.
Published: (2024)

Editorial: Pharmacogenetics Research and Clinical Applications: An International Landscape of the Accomplishments, Challenges, and Opportunities
by: Nathalie K. Zgheib, et al.
Published: (2020)

Independent Community Pharmacists’ Experience in Offering Pharmacogenetic Testing
by: Haga SB, et al.
Published: (2021)

Pharmacogenetics in Practice: Estimating the Clinical Actionability of Pharmacogenetic Testing in Perioperative and Ambulatory Settings
by: D. Max Smith, et al.
Published: (2020)

Effect of Fluid Therapy in Early Morning on the Incidence of Post-Induction Hypotension During Non-Cardiac Surgery After Noon: A Single-Center Retrospective Study
by: Zhang Y, et al.
Published: (2024)

Barriers to Implementing Clinical Pharmacogenetics Testing in Sub-Saharan Africa. A Critical Review
by: Emiliene B. Tata, et al.
Published: (2020)

Real‐world implementation of DPYD and UGT1A1 pharmacogenetic testing in a community‐based cancer center
by: Megan Muldoon, et al.
Published: (2024)

Ten-year experience with pharmacogenetic testing for DPYD in a national cancer center in Italy: Lessons learned on the path to implementation
by: A. Bignucolo, et al.
Published: (2023)

Improving single nucleotide polymorphisms genotyping accuracy for dihydropyrimidine dehydrogenase testing in pharmacogenetics
by: Annalaura Montella, et al.
Published: (2024)

Early Rehabilitation Activity and Rehabilitation in ICU Wards in Central China: A Cross-Sectional Survey
by: Zhang Y, et al.
Published: (2024)

Reimbursement of pharmacogenetic tests at a tertiary academic medical center in the United States
by: Lauren K. Lemke, et al.
Published: (2023)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015)

PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
by: N. V. Shcherbakova, et al.
Published: (2015)

Non-Selective Alpha-Blockers Provide More Stable Intraoperative Hemodynamic Control Compared with Selective Alpha1-Blockers in Patients with Pheochromocytoma and Paraganglioma: A Single-Center Retrospective Cohort Study with a Propensity Score-Matched Analysis from China
by: Yang Y, et al.
Published: (2022)

Small bowel gastrointestinal stromal tumor: a retrospective study of 32 cases at a single center and review of the literature
by: Zhou L, et al.
Published: (2018)

Implementation of a pharmacogenetic panel‐based test for pharmacotherapy‐based supportive care in an adult oncology clinic
by: Emily J. Cicali, et al.
Published: (2024)

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
by: Sony Tuteja, et al.
Published: (2022)

Recent landscape and trends for industry‐sponsored pediatric clinical trials in China from 2013 to 2022
by: Chang Liu, et al.
Published: (2024)

Delivery of Pharmacogenetic Testing with or without Medication Therapy Management in a Community Pharmacy Setting
by: Haga SB, et al.
Published: (2021)

Pharmacogenetic testing: current state of the issue
by: O. V. Kraidashenko, et al.
Published: (2024)

Economic burden of pertussis in children: A single-center analysis in Hangzhou, China
by: Yan Liu, et al.
Published: (2024)

Community Health Centers’ Responsiveness and Its Associated Factors Among Outpatients in Southeast China: A Cross-Sectional Study
by: Zhou C, et al.
Published: (2024)

Clinical Implementation of DPYD Pharmacogenetic Testing to Prevent Early-Onset Fluoropyrimidine-Related Toxicity in Cancer Patients in Switzerland
by: Ursina B. M. Begré, et al.
Published: (2022)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
by: Angela Wu, et al.
Published: (2023)

Performance Evaluation of Noninvasive Prenatal Testing in Screening Chromosome Disorders: A Single-Center Observational Study of 15,304 Consecutive Cases in China
by: Ye Q, et al.
Published: (2024)

Establishment and implementation of a nurse-led interdisciplinary management strategy for central line maintenance: A single-center experience
by: Yuxin Yin, et al.
Published: (2023)

Clinicopathological Characteristics and Outcome of Cytophagic Histiocytic Panniculitis: A Single-Center, Retrospective Study
by: Su T, et al.
Published: (2024)

A Multi-Center Study of Automated Breast Ultrasound System for the Diagnosis of Breast Cancer in China
by: M.-M. Jia, et al.
Published: (2017)

The basic principals of pharmacogenetics testing in cancer treatment
by: Cikota-Aleksić Bojana M., et al.
Published: (2020)

Characterizing Pharmacogenetic Testing Among Children's Hospitals
by: Jacob T. Brown, et al.
Published: (2021)

Pharmacogenetics and predictive testing of drug hypersensitivity reactions
by: Ruwen Boehm, et al.
Published: (2016)

Implementing pharmacogenetic testing in fluoropyrimidine-treated cancer patients: DPYD genotyping to guide chemotherapy dosing in Greece
by: Georgia Ragia, et al.
Published: (2023)

Impact of Paroxysmal Atrial Tachycardia on Thromboembolic Events and Major Adverse Cardiovascular Events: A Single-Center Retrospective Study
by: Liu P, et al.
Published: (2024)

Application of pharmacogenetics in oncology
by: Nelly N. Miteva-Marcheva, et al.
Published: (2020)

Incidence of Adverse Events in Central Sterile Supply Department: A Single-Center Retrospective Study
by: Chen H, et al.
Published: (2023)

The Clinicopathological Features and Prognoses of Lower Uterine Segment Cancer: A Retrospective, Single-Center Cohort Study
by: Wang H, et al.
Published: (2024)

Fertility preservation among young breast cancer patients: A single-center experience in China
by: Qi Wan, et al.
Published: (2021)